Our tRNA m5C methylation sequencing service supports research teams that need site-level information on 5-methylcytosine (m5C) across transfer RNA populations. The workflow combines tRNA-focused sample preparation, RNA bisulfite conversion, next-generation sequencing, and tRNA-aware bioinformatics to identify cytosines that remain unconverted under controlled conditions and to estimate methylation levels at supported positions.
Because tRNAs are short, highly structured, densely modified, and frequently represented by closely related gene copies, reliable tRNA m5C sequencing requires more than a standard RNA bisulfite protocol. We plan each project around sample type, organism, target tRNA scope, expected biological comparison, reference quality, conversion controls, and coverage needs so that the resulting data can support practical decisions about methyltransferase activity, tRNA stability, stress responses, and translation-related research.
Fig 1. The distribution of methylation in mRNA. (Song H, 2022)
Incomplete Cytosine Conversion: Residual unconverted cytosines can be mistaken for m5C when tRNA structure limits reagent access. We incorporate denaturation strategy review, conversion controls, and site-level filtering so that methylation calls are interpreted against measured conversion performance rather than read counts alone.
RNA Damage During Treatment: Bisulfite exposure can fragment RNA and reduce usable library complexity. The workflow is configured to balance conversion stringency with RNA recovery, while library preparation and sequencing depth are planned around the expected loss of intact tRNA-derived molecules.
Reverse-Transcription Barriers: tRNAs contain multiple modifications that can impede or alter reverse transcription. We assess whether the project requires standard profiling, modification-aware library strategies, or complementary tRNA sequencing to separate methylation effects from broader RT-related bias.
Isodecoder and Multi-Mapping Ambiguity: Closely related tRNA genes can generate reads that cannot be assigned uniquely. Our analysis uses mature tRNA references, family-aware annotation, and transparent ambiguity rules to report results at the most defensible gene, isodecoder, isotype, or family level.
Low-Coverage Site Inflation: Apparent methylation differences can be driven by sparse reads or uneven tRNA abundance. We apply coverage, conversion, replicate, and effect-size criteria before prioritizing candidate sites, and we distinguish exploratory observations from higher-confidence results.
Fig 2. Principle of m5C detection by RNA bisulfite sequencing. (Motorin Y, 2009)
Our service is designed for comparative and mechanistic studies of tRNA cytosine-5 methylation. Projects may begin with purified tRNA, total RNA, or biological material requiring RNA extraction, depending on sample quality and the agreed scope. Experimental and computational modules can be combined into a complete workflow or selected to complement an existing study.
Each project plan defines the analysis level, control strategy, sequencing design, and reporting criteria before laboratory work begins. This helps align assay sensitivity with the customer's biological question and reduces the risk of generating data that cannot be assigned confidently across highly similar tRNA sequences.
The appropriate service configuration depends on whether the study is exploratory, comparative, or focused on defined tRNA substrates. The table below summarizes common project formats and the decisions they are designed to support.
| Project Format | Best Suited For | Core Experimental Scope | Primary Deliverables | Key Planning Considerations |
| Discovery Profiling | Initial mapping of tRNA m5C patterns within one sample class | tRNA preparation, bisulfite conversion, library construction, sequencing, and site calling | QC summary, mapped-read statistics, supported m5C site table, methylation estimates, and profile plots | Reference quality, sequencing depth, expected tRNA diversity, and confidence thresholds |
| Comparative Profiling | Treatment, genotype, condition, or time-point comparisons | Matched conversion and sequencing workflow across biological groups | Group-level site matrices, differential methylation results, clustering, and prioritized candidates | Biological replication, batch balance, effect size, and minimum site coverage |
| Candidate tRNA Panel | Focused analysis of selected tRNAs or positions | Targeted enrichment or locus-focused amplification after conversion, as technically appropriate | Candidate-site methylation estimates, coverage metrics, and sample-level comparisons | Primer feasibility, paralog similarity, target abundance, and assay-specific controls |
| Enzyme Perturbation Study | Evaluation of NSUN2-, DNMT2-, or other candidate methyltransferase-dependent changes | Comparative profiling across control and perturbed samples | Lost, gained, or altered candidate sites; substrate prioritization; structural-position summaries | Perturbation efficiency, indirect effects, tRNA abundance changes, and replicate design |
| Multi-Omics Study | Linking tRNA m5C with abundance, fragmentation, or translation-related measurements | m5C sequencing plus selected complementary assays or customer-provided datasets | Integrated matrices, cross-assay plots, correlation summaries, and interpretation framework | Matched samples, compatible normalization, temporal alignment, and limits of causal inference |
tRNA m5C data require dedicated processing because bisulfite conversion lowers sequence complexity and tRNA loci are often difficult to distinguish. Our analysis framework reports both biological results and the technical evidence supporting each result.
| Analysis Module | What Is Evaluated | Typical Output | Decision Value | Important Limitation |
| Raw Data QC | Base quality, adapter content, read length, duplication, and library complexity | Per-sample QC report and cleaned-read summary | Confirms whether libraries are suitable for downstream mapping | High read count does not guarantee broad tRNA or site coverage |
| Conversion QC | Non-conversion background in controls and accessible cytosines | Conversion metrics and sample flags | Defines the background against which retained cytosines are interpreted | Structured regions may convert differently from control molecules |
| tRNA Mapping | Alignment to mature and genomic tRNA references with ambiguity handling | Mapping rates, unique and multi-mapped fractions, family assignments | Establishes the resolution supported by the sequence data | Some isodecoders cannot be separated with short reads |
| Site Quantification | Converted and unconverted observations at each cytosine | Coverage, retained-C counts, estimated methylation proportion, confidence flags | Enables ranking of candidate m5C positions | Retained cytosine can reflect incomplete conversion, not only m5C |
| Structural Annotation | Position of candidate sites within tRNA stems, loops, variable region, and acceptor arm | Position maps and region-level summaries | Supports comparison with expected methyltransferase substrate patterns | Mature tRNA numbering and organism-specific annotations may require curation |
| Differential Testing | Group differences in methylation proportion at adequately covered sites | Effect sizes, statistical results, heatmaps, and prioritized site lists | Identifies condition-associated methylation changes | Sparse sites and low replicate numbers reduce statistical power |
| Integrated Interpretation | Relationship of m5C changes to tRNA abundance, fragments, perturbations, or metadata | Correlation plots, grouped summaries, and follow-up recommendations | Helps separate modification changes from shifts in tRNA composition | Correlation alone does not establish direct methyltransferase-substrate causality |
The workflow is organized to protect sample comparability and to make conversion, mapping, and site-calling limitations visible before biological conclusions are drawn.
We confirm the organism, sample matrix, group design, replicate structure, target tRNAs, available RNA amount, and intended analysis resolution. This step determines whether the project should use global profiling, a targeted panel, or a combined tRNA modification strategy.
We review tRNA reference quality, expected multi-mapping, conversion controls, library strategy, sequencing depth, and methylation-calling criteria. The customer receives a defined scope that connects each laboratory step to a specific deliverable.
Samples undergo agreed intake QC, RNA extraction or tRNA enrichment, normalization, and batch assignment. These controls help reduce variation caused by RNA degradation, contaminating nucleic acids, or unequal tRNA representation before conversion.
RNA is denatured and subjected to bisulfite conversion, followed by recovery, reverse transcription, amplification, and library QC. Conversion performance and material loss are reviewed before libraries advance to sequencing.
Libraries are sequenced and processed through conversion-aware QC, tRNA-focused mapping, site quantification, structural annotation, and differential analysis. Ambiguous assignments and low-support sites are flagged rather than presented as equivalent to high-confidence calls.
We deliver the agreed raw data, processed tables, figures, methods, QC interpretation, and prioritized findings. Post-delivery discussion focuses on result boundaries, candidate validation, and complementary experiments that may strengthen the study.
Our service is structured around the technical realities of tRNA and RNA bisulfite sequencing. The goal is not simply to generate reads, but to deliver methylation results with clear evidence, appropriate resolution, and practical interpretation limits.
tRNA m5C sequencing can support research programs investigating how cytosine methylation varies across tRNA species, structural positions, perturbations, and environmental conditions. The assay is most informative when methylation measurements are interpreted together with tRNA abundance, enzyme activity, or functional readouts.
A successful tRNA m5C methylation sequencing project begins with a realistic assessment of sample quality, conversion controls, tRNA reference resolution, and the biological comparison that must be supported. Whether your study requires a discovery map, a methyltransferase perturbation comparison, a focused tRNA panel, or integration with expression and fragment data, our team can help define a technically appropriate workflow and deliverables. Contact us to discuss your sample type, organism, study design, and preferred analysis outputs.
We employ multiple approaches including RNA bisulfite sequencing for single-base resolution, m5C-RIP for antibody-based enrichment, Aza-IP for methyltransferase-specific sites, and miCLIP for precise mapping of modification sites.
m5C modifications influence tRNA stability, translation accuracy, and cellular stress responses, making them valuable for studying gene regulation and protein synthesis mechanisms.
High-quality tRNA samples with minimal degradation are essential. We recommend providing purified tRNA with clear documentation of source material and handling conditions.
Our comprehensive analysis covers methylation site identification, differential methylation analysis, modification density mapping, functional annotation, and visualization of methylation patterns across tRNA regions.
Yes, our service includes comparative analysis of methylation levels, identification of differentially methylated regions, and statistical evaluation of methylation changes between sample groups.
We utilize high-depth sequencing, optimized library preparation protocols, and sensitive detection algorithms to reliably identify even low-frequency methylation events in complex tRNA samples.
Loading ......
